Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/75025
DC FieldValueLanguage
dc.contributor.authorNavarro, Eduardoen_US
dc.contributor.authorAlonso, S. J.en_US
dc.contributor.authorNavarro Garcia, Ricardoen_US
dc.date.accessioned2020-10-27T09:29:50Z-
dc.date.available2020-10-27T09:29:50Z-
dc.date.issued2011en_US
dc.identifier.issn1741-427Xen_US
dc.identifier.otherScopus-
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/75025-
dc.description.abstractElenine is the aglycone of elenoside, a cytotoxic arylnaphthalene lignan (NSC 644013-W/1) derived from Justicia hyssopifolia. (Family: Acanthaceae). Elenoside is a -D-glucoside, with a similar chemical structure to etoposide, exhibiting central depressant activity. In the present study, elenine was given to mice and rats at doses of 10, 20, and 40mg/kg. Acute toxicity (24h) and general behaviour in mice was studied as well as its effects on muscular relaxant activity, locomotor activity (Varimex test), and the open-field test and were compared with 10mg/kg of chlorpromazine. Elenine produced a reduction in the permanence time in muscular relaxant activity (traction test). Spontaneous activity was lower in the Varimex test. The ambulation and rearing were lower compared with the control group, and an increase in boluses was observed in the open-field test. Thus, it can be concluded that elenine has central sedative effects at lower doses than those used with elenoside and has a possible application in conditions of anxiety.en_US
dc.languageengen_US
dc.relation.ispartofEvidence-Based Complementary and Alternative Medicineen_US
dc.sourceEvidence-based Complementary and Alternative Medicine [ISSN 1741-427X], v. 2011en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherSex-Differences-
dc.subject.otherElenoside-
dc.subject.otherLignans-
dc.titleToxicity and neuropharmacological effects of elenineen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1155/2011/312524en_US
dc.identifier.scopus80052744981-
dc.identifier.isi000293411100001-
dc.contributor.authorscopusid56273603700-
dc.contributor.authorscopusid7102615168-
dc.contributor.authorscopusid7202829137-
dc.identifier.eissn1741-4288-
dc.relation.volume2011en_US
dc.investigacionCiencias de la Salud-
dc.type2Artículoen_US
dc.contributor.daisngid1970623-
dc.contributor.daisngid1674878-
dc.contributor.daisngid5501662-
dc.description.numberofpages10en_US
dc.utils.revision-
dc.contributor.wosstandardWOS:Navarro, E-
dc.contributor.wosstandardWOS:Alonso, SJ-
dc.contributor.wosstandardWOS:Navarro, R-
dc.date.coverdateSeptiembre 2011en_US
dc.identifier.ulpgc-
dc.description.sjr0,786
dc.description.jcr4,774
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.fulltextCon texto completo-
item.grantfulltextopen-
crisitem.author.fullNameNavarro Garcia, Ricardo-
Appears in Collections:Artículos
Unknown (1,49 MB)
Show simple item record

SCOPUSTM   
Citations

8
checked on Nov 3, 2024

WEB OF SCIENCETM
Citations

7
checked on Nov 3, 2024

Page view(s)

256
checked on May 4, 2024

Download(s)

154
checked on May 4, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.